| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,233 |
3,815 |
$155K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,483 |
1,478 |
$118K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,443 |
1,351 |
$112K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,006 |
3,817 |
$108K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,106 |
1,096 |
$93K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
665 |
624 |
$88K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
664 |
654 |
$60K |
| 99429 |
|
1,715 |
1,703 |
$57K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,619 |
1,564 |
$22K |
| 87428 |
|
230 |
228 |
$17K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,487 |
1,481 |
$12K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
323 |
315 |
$12K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
338 |
295 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
571 |
277 |
$7K |
| 90461 |
|
1,185 |
1,015 |
$7K |
| 87631 |
|
62 |
61 |
$7K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
118 |
109 |
$6K |
| 99383 |
|
56 |
56 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
53 |
51 |
$4K |
| 0071A |
|
86 |
84 |
$3K |
| 99384 |
|
33 |
32 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
53 |
51 |
$3K |
| 0072A |
|
53 |
53 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
75 |
74 |
$2K |
| 96160 |
|
850 |
839 |
$2K |
| 99382 |
|
12 |
12 |
$1K |
| 99000 |
|
111 |
109 |
$997.32 |
| 99381 |
|
18 |
15 |
$895.80 |
| 87807 |
|
82 |
79 |
$891.00 |
| 0001A |
|
17 |
15 |
$640.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
104 |
103 |
$284.24 |
| 90677 |
|
230 |
227 |
$0.87 |
| 91307 |
|
163 |
155 |
$0.84 |
| 90744 |
|
332 |
331 |
$0.00 |
| 90716 |
|
359 |
357 |
$0.00 |
| 90686 |
|
706 |
700 |
$0.00 |
| 90680 |
|
572 |
572 |
$0.00 |
| 90651 |
|
183 |
180 |
$0.00 |
| 90656 |
|
137 |
137 |
$0.00 |
| 90700 |
|
1,429 |
1,423 |
$0.00 |
| 90670 |
|
861 |
859 |
$0.00 |
| 90713 |
|
1,124 |
1,116 |
$0.00 |
| 90648 |
|
1,103 |
1,100 |
$0.00 |
| 90707 |
|
372 |
370 |
$0.00 |
| 90633 |
|
423 |
420 |
$0.00 |
| 90734 |
|
175 |
173 |
$0.00 |
| 90715 |
|
49 |
49 |
$0.00 |
| 91300 |
|
29 |
29 |
$0.00 |
| 90685 |
|
18 |
18 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
18 |
18 |
$0.00 |